MedPath

重庆药友制药有限责任公司

Ownership
-
Established
1997-07-21
Employees
-
Market Cap
-
Website
https://www.yaopharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

315

NMPA:315

Drug Approvals

Levodopa and Benserazide Hydrochloride Tablets

Product Name
多巴丝肼片
Approval Number
国药准字H20254523
Approval Date
Jun 10, 2025
NMPA

Dacomitinib Tablets

Product Name
达可替尼片
Approval Number
国药准字H20254264
Approval Date
May 27, 2025
NMPA

Methocarbamol Injection

Product Name
美索巴莫注射液
Approval Number
国药准字H20258079
Approval Date
May 9, 2025
NMPA

Etomidate Medium and Long Chain Fat Emulsion Injection

Product Name
依托咪酯中/长链脂肪乳注射液
Approval Number
国药准字H20254019
Approval Date
Apr 30, 2025
NMPA

Metformin Hydrochloride Extended-release Tablets

Product Name
盐酸二甲双胍缓释片
Approval Number
国药准字H20253450
Approval Date
Feb 25, 2025
NMPA

Ademetionine Butanedisulfonate for Injection

Product Name
注射用丁二磺酸腺苷蛋氨酸
Approval Number
国药准字H20249503
Approval Date
Dec 1, 2024
NMPA

Regorafenib Tablets

Product Name
瑞戈非尼片
Approval Number
国药准字H20249282
Approval Date
Nov 5, 2024
NMPA

Roxatidine Acetate Hydrochloride for Injection

Product Name
注射用盐酸罗沙替丁醋酸酯
Approval Number
国药准字H20249114
Approval Date
Oct 22, 2024
NMPA

Lenvatinib Mesilate Capsules

Product Name
甲磺酸仑伐替尼胶囊
Approval Number
国药准字H20249044
Approval Date
Oct 9, 2024
NMPA

Lenvatinib Mesilate Capsules

Product Name
甲磺酸仑伐替尼胶囊
Approval Number
国药准字H20249022
Approval Date
Oct 9, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 32
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.